200 related articles for article (PubMed ID: 34405304)
1. Long-circulating XTEN864-annexin A5 fusion protein for phosphatidylserine-related therapeutic applications.
Haeckel A; Ascher L; Beindorff N; Prasad S; Garczyńska K; Guo J; Schellenberger E
Apoptosis; 2021 Oct; 26(9-10):534-547. PubMed ID: 34405304
[TBL] [Abstract][Full Text] [Related]
2. XTEN-annexin A5: XTEN allows complete expression of long-circulating protein-based imaging probes as recombinant alternative to PEGylation.
Haeckel A; Appler F; Figge L; Kratz H; Lukas M; Michel R; Schnorr J; Zille M; Hamm B; Schellenberger E
J Nucl Med; 2014 Mar; 55(3):508-14. PubMed ID: 24549285
[TBL] [Abstract][Full Text] [Related]
3. AnxA5 reduces plaque inflammation of advanced atherosclerotic lesions in apoE(-/-) mice.
Burgmaier M; Schutters K; Willems B; van der Vorst EP; Kusters D; Chatrou M; Norling L; Biessen EA; Cleutjens J; Perretti M; Schurgers LJ; Reutelingsperger CP
J Cell Mol Med; 2014 Oct; 18(10):2117-24. PubMed ID: 25214012
[TBL] [Abstract][Full Text] [Related]
4. Annexin A5 reduces early plaque formation in ApoE -/- mice.
Stöhr R; Schurgers L; van Gorp R; Jaminon A; Marx N; Reutelingsperger C
PLoS One; 2017; 12(12):e0190229. PubMed ID: 29267398
[TBL] [Abstract][Full Text] [Related]
5. Past, present, and future of annexin A5: from protein discovery to clinical applications.
Boersma HH; Kietselaer BL; Stolk LM; Bennaghmouch A; Hofstra L; Narula J; Heidendal GA; Reutelingsperger CP
J Nucl Med; 2005 Dec; 46(12):2035-50. PubMed ID: 16330568
[TBL] [Abstract][Full Text] [Related]
6. Domain IV of Annexin A5 Is Critical for Binding Calcium and Guarantees Its Maximum Binding to the Phosphatidylserine Membrane.
Wang J; Liu J; Cao Y; Hu M; Hua Z
Molecules; 2017 Dec; 22(12):. PubMed ID: 29257055
[No Abstract] [Full Text] [Related]
7. Site-specifically 11C-labeled Sel-tagged annexin A5 and a size-matched control for dynamic in vivo PET imaging of protein distribution in tissues prior to and after induced cell death.
Cheng Q; Lu L; Grafström J; Olofsson MH; Thorell JO; Samén E; Johansson K; Ahlzén HS; Linder S; Arnér ES; Stone-Elander S
Biochim Biophys Acta; 2013 Mar; 1830(3):2562-73. PubMed ID: 23262140
[TBL] [Abstract][Full Text] [Related]
8. Annexin A5 prevents post-interventional accelerated atherosclerosis development in a dose-dependent fashion in mice.
Ewing MM; Karper JC; Sampietro ML; de Vries MR; Pettersson K; Jukema JW; Quax PH
Atherosclerosis; 2012 Apr; 221(2):333-40. PubMed ID: 22341596
[TBL] [Abstract][Full Text] [Related]
9. Annexin A5 down-regulates surface expression of tissue factor: a novel mechanism of regulating the membrane receptor repertoir.
Ravassa S; Bennaghmouch A; Kenis H; Lindhout T; Hackeng T; Narula J; Hofstra L; Reutelingsperger C
J Biol Chem; 2005 Feb; 280(7):6028-35. PubMed ID: 15576370
[TBL] [Abstract][Full Text] [Related]
10. Annexin A5 binds to lipopolysaccharide and reduces its endotoxin activity.
Rand JH; Wu XX; Lin EY; Griffel A; Gialanella P; McKitrick JC
mBio; 2012; 3(2):. PubMed ID: 22415004
[TBL] [Abstract][Full Text] [Related]
11. Molecular imaging of cell death in tumors. Increasing annexin A5 size reduces contribution of phosphatidylserine-targeting function to tumor uptake.
Ungethüm L; Chatrou M; Kusters D; Schurgers L; Reutelingsperger CP
PLoS One; 2014; 9(5):e96749. PubMed ID: 24801051
[TBL] [Abstract][Full Text] [Related]
12. Site-specific 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis.
Bauwens M; De Saint-Hubert M; Devos E; Deckers N; Reutelingsperger C; Mortelmans L; Himmelreich U; Mottaghy FM; Verbruggen A
Nucl Med Biol; 2011 Apr; 38(3):381-92. PubMed ID: 21492787
[TBL] [Abstract][Full Text] [Related]
13. Cell surface-expressed phosphatidylserine as therapeutic target to enhance phagocytosis of apoptotic cells.
Schutters K; Kusters DH; Chatrou ML; Montero-Melendez T; Donners M; Deckers NM; Krysko DV; Vandenabeele P; Perretti M; Schurgers LJ; Reutelingsperger CP
Cell Death Differ; 2013 Jan; 20(1):49-56. PubMed ID: 22955945
[TBL] [Abstract][Full Text] [Related]
14. Engineered annexin A5 variants have impaired cell entry for molecular imaging of apoptosis using pretargeting strategies.
Ungethüm L; Kenis H; Nicolaes GA; Autin L; Stoilova-McPhie S; Reutelingsperger CP
J Biol Chem; 2011 Jan; 286(3):1903-10. PubMed ID: 21078669
[TBL] [Abstract][Full Text] [Related]
15. Annexin A5 as a targeting agent for cancer treatment.
Woodward A; Faria GNF; Harrison RG
Cancer Lett; 2022 Oct; 547():215857. PubMed ID: 35940392
[TBL] [Abstract][Full Text] [Related]
16. Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment.
Kang TH; Park JH; Yang A; Park HJ; Lee SE; Kim YS; Jang GY; Farmer E; Lam B; Park YM; Hung CF
Nat Commun; 2020 Feb; 11(1):1137. PubMed ID: 32111835
[TBL] [Abstract][Full Text] [Related]
17. Annexin V expression on CD4
Bollinger AL; Bollinger T; Rupp J; Shima K; Gross N; Padayachy L; Chicheportiche R; Puga Yung GL; Seebach JD
Immunology; 2020 Feb; 159(2):205-220. PubMed ID: 31642515
[TBL] [Abstract][Full Text] [Related]
18. Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli.
McKernan P; Cassidy B; Woodward A; Battiste J; Drevets D; Harrison R
Int J Antimicrob Agents; 2020 Dec; 56(6):106183. PubMed ID: 33045345
[TBL] [Abstract][Full Text] [Related]
19. Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: molecular imaging with 14C-FDG and 99mTc-annexin A5.
Zhao Y; Watanabe A; Zhao S; Kobayashi T; Fukao K; Tanaka Y; Nakano T; Yoshida T; Takemoto H; Tamaki N; Kuge Y
PLoS One; 2014; 9(2):e89338. PubMed ID: 24586699
[TBL] [Abstract][Full Text] [Related]
20. Gold fluorescent annexin A5 as a novel apoptosis detection tool.
Kurschus FC; Pal PP; Bäumler P; Jenne DE; Wiltschi B; Budisa N
Cytometry A; 2009 Jul; 75(7):626-33. PubMed ID: 19437539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
